Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VGN-R08b in GBA1-Mutated Parkinson's Disease
CTR20260441Phase 2Active
- Sponsor
- T-MAXESTATE
- Start
- Feb 2026
- Modality
- Small Molecules, AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of VGN-R08b in GBA-Associated Parkinsonism (GBA-PD), sponsored by T-MAXESTATE. Started Feb 2026; status: active.
02
Drugs
VGN-R08b
03
Conditions
GBA-Associated Parkinsonism (GBA-PD)
Beyond the preview
Go deeper on CTR20260441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260441.